Tubeless Insulin Pump Market

Global Tubeless Insulin Pump Market is valued at USD 1.58 Billion in 2021 and is expected to reach USD 6.35 Million by 2028 with a CAGR of 21.93% over the forecast period.

Escalating the prevalence of diabetes and obesity, the growing geriatric population, and technological advancement in tubeless insulin delivery are some factors driving the growth of the market.

Scope of Tubless Insulin Pump Market Report:

Insulin Pump which is also referred to as continuous subcutaneous insulin infusion is rapidly gaining popularity across the medical device industry. This medical device makes use of a near-physiologic basal-bolus procedure for the delivery of insulin and it is a flexible as well as lifestyle-friendly method. Insulin pump without tubing (patch pump), Tubeless patch pumps contain the insulin reservoir and the infusion cannula and adhere directly to the skin. A handheld device is used to program insulin delivery and insert the infusion cannula. This tubeless patch pump (pod) is operated by a handheld device called the “PDM” that is wirelessly connected to Bluetooth.

Moreover, tubeless insulin pumps are tiny, unobtrusive, and lightweight in nature and are also referred to as insulin patch pumps. These products are discrete, cost-effective, easily adhere to human skin, and easy to use.  Currently, these pumps make use of nitinol wire, spring, step motor, piezoelectric crystal, manual pumping chamber, and bladder for insulin delivery. These tubeless insulin pumps are available in myriad sizes and technologies. These products can be worn and effectively handled under clothing.

Global Tubeless Insulin Pump Market Dynamics:-

With mounting cases of diabetes, especially among geriatric patients, the tubeless insulin pump market is estimated to witness significant growth over the forecast period. According to American Diabetes Association,  In 2018, 34.2 million Americans, or 10.5% of the population, had diabetes. Almost 1.6 million Americans have type 1 diabetes, including about 187,000 children and adolescents. Additionally, the Development of novel insulin delivery devices will further boost the market growth. Lightweight and disposable pod such as Omnipod, by Ypsomed, endlessly deliver insulin for up to three days and is connected with a remote to conclude insulin delivery intervals. Correspondingly, in March 2019, the United States FDA gave fast-track title to EoPancreas, an Automated Insulin Delivery (AID) system, by EoFlow. However, partial reimbursement for tubeless insulin pumps and the drastically rising cost of insulin delivery systems may hinder the market growth in forthcoming years. Moreover, new products to the product line and the constant addition of new features to the existing products will boost the market opportunity over the coming years.

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2021:	USD 1.58 Billion
Base year considered	2021
Forecast Period CAGR %:	21.93%
Market Size Expected in 2028:	USD 6.35 Billion
Tables, Charts & Figures:	175
Pages	200
Tubeless Insulin Pump Companies	Insulet Corporation, Johnson & Johnson, Medtrum Technologies, Cellnova, Roche Holdings, Spring Health Solutions, Debiotech, CeQur, Valeritas Holding, Abbott Diabetes Care, Medtronic Plc., Tandem Diabetes Care, Insulet Corporation, Animas Corporation, Others
Segments Covered	By Component, By Distribution Channel
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Global Tubeless Insulin Pumps Market Regional Analysis:

North America dominates the tubeless insulin pumps market, due to factors such as the rising population base suffering from diabetes as well as increasing spending on insulin uptake per person will highly impact the demand for the tubeless insulin pump market in this region. According to Canadian Community Health Survey, in 2017, 7.3% of Canadians aged 12 and older (roughly 2.3 million people) reported being diagnosed with diabetes. In addition, new product launches and continuous up-gradation in technology will expand market growth in the forecast period.

Asia-Pacific is expected to be the highest growing region due to increasing government initiatives to enhance awareness about effective diabetes management. For example, the Australian Ministry of Health funded 100 million for extending promotional action of insulin, in the year 2018. The project provides fully subsidized insulin monitor devices to patients age below 21 years of age that are affected with diabetes. Hence, increasing government initiatives and diabetes care awareness among patients will raise the demand for the tubeless insulin pump market in this region.

Tubeless Insulin Pump Market Segmentation:

Global tubeless insulin pump market is segmented on the basis of component, distribution channel, and region. On the basis of components, the market is segmented into pod/patch, remote, and others. On the basis of distribution channels, the market is segmented into hospitals, pharmacies, e-commerce, and others.

By Component

• Pod/patch
• Remote
• Others

By Distribution Channel

• Hospitals
• Pharmacies
• E-commerce
• Others

Insulin Pump Market Key Players

• Insulet Corporation
•  Johnson & Johnson
• Medtrum Technologies
• Cellnova
• Roche Holdings
• Spring Health Solutions
• Debiotech
• CeQur
• Valeritas Holding
• Abbott Diabetes Care
• Medtronic Plc.
• Tandem Diabetes Care
• Insulet Corporation
• Animas Corporation
• Others

On Special Requirement tubeless insulin pumps market Report is also available for below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Key Benefits for Global Tubeless Insulin Pumps Reports:-

• Global Tubeless Insulin Pump report covers in-depth historical and forecast analysis.
• Global Tubeless Insulin Pump research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Insulin pump Manufacturers, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global Tubeless Insulin Pump report helps to identify opportunities in the marketplace.
• Global Tubeless Insulin Pump report covers extensive analysis of emerging trends and competitive landscape.